Treatment Persistence After Major Cardiovascular Events in Psoriasis: A Retrospective Cohort Study Comparing Biologic, Systemic, and Phototherapy
The Journal of Dermatology · 2025
DOI: 10.1111/1346-8138.17949 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Hyun Keun Ahn und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Seoul National University Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Psoriasis, Cardiovascular Diseases, Biological Products, Phototherapy. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seoul Metropolitan Government Seoul National University Boramae Medical Center.
Abstract (Originalsprache)
Patients with psoriasis experience significantly higher cardiovascular morbidity compared to the general population. Although certain psoriasis treatments may confer cardioprotective effects, current clinical guidelines addressing treatment continuation following major adverse cardiovascular events (MACE) are lacking. Therefore, we conducted a retrospective cohort study using Korean health insurance data (January 2008–October 2021) to examine treatment modifications after MACE in patients with psoriasis. Patients were categorized based on treatment type: biologics, non‐biologic systemic agents (cyclosporine or methotrexate), and phototherapy. Treatment persistence within 3 months after MACE was assessed using multivariable logistic regression, adjusted for demographic and clinical factors. Subgroup analyses were conducted based on previous MACE history. This retrospective cohort study included 1012 patients with MACE history and 2981 without. Biologic therapies demonstrated significantly superior treatment persistence (79.7%) compared to non‐biologic systemic therapies (46.9%) and phototherapy (47.0%). Switching therapies was uncommon across all treatment groups (0.8%–1.9%). Multivariable logistic regression analysis confirmed that biologics were associated with greater treatment persistence than cyclosporine (odds ratio [OR], 4.854; 95% confidence interval [CI], 2.476–9.516), methotrexate (OR, 3.616; 95% CI, 1.760–7.431), and phototherapy (OR, 4.556; 95% CI, 2.340–8.873). These findings remained consistent in both the new‐onset and recurrent MACE subgroups. No significant difference in treatment persistence was observed between the non‐biologic systemic therapy and phototherapy groups. In conclusion, patients receiving biologic therapies were more likely to continue treatment after a cardiovascular event compared to those receiving other therapies. These findings suggest that biologics are perceived as safer options in this high‐risk population and underscore the need for clear, evidence‐based guidance on psoriasis treatment following cardiovascular events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Seoul National University Hospital, Seoul, Korea.
- Medical Research Collaborating Center, SMG-SNU Boramae Medical Center, Seoul, Korea.
- Department of Dermatology, SMG-SNU Boramae Medical Center, Seoul, Korea.
- Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.
ORCID-Profile: Hyun Keun Ahn, Sohee Oh
Förderung
- Seoul Metropolitan Government Seoul National University Boramae Medical Center
Zitieren
APA
Ahn, H. K., Oh, S., & Yoon, H. S. (2025). Treatment Persistence After Major Cardiovascular Events in Psoriasis: A Retrospective Cohort Study Comparing Biologic, Systemic, and Phototherapy. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17949
Vancouver
Ahn HK, Oh S, Yoon HS. Treatment Persistence After Major Cardiovascular Events in Psoriasis: A Retrospective Cohort Study Comparing Biologic, Systemic, and Phototherapy. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17949
BibTeX
@article{Ahn2025,
author = {Ahn, Hyun Keun and Oh, Sohee and Yoon, Hyun-Sun},
title = {Treatment Persistence After Major Cardiovascular Events in Psoriasis: A Retrospective Cohort Study Comparing Biologic, Systemic, and Phototherapy},
journal = {The Journal of Dermatology},
year = {2025},
doi = {10.1111/1346-8138.17949}
}
EUVIMED